6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine,
entospletinib,
GS-9973,
Entospletinib,
1229208-44-9,
GS-9973,
Entospletinib (GS-9973),
6-(1H-Indazol-6-yl)-N-(4-morpholinophenyl)imidazo[1,2-a]pyrazin-8-amine,
UNII-6I3O3W6O3B,
gs9973,
GS 9973,
6I3O3W6O3B,
CHEMBL3265032,
C23H21N7O,
6-(1H-Indazol-6-yl)-N-(4-(morpholin-4-yl)phenyl)imidazo(1,2-a)pyrazin-8-amine,
Imidazo(1,2-a)pyrazin-8-amine, 6-(1H-indazol-6-yl)-N-(4-(4-morpholinyl)phenyl)-,
Entospletinib [INN],
Entospletinib [USAN:INN],
4puz,
6-(1h-Indazol-6-Yl)-N-[4-(Morpholin-4-Yl)phenyl]imidazo[1,2-A]pyrazin-8-Amine,
Imidazo[1,2-a]pyrazin-8-amine, 6-(1H-indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]-,
GS-9973; Entospletinib,
GTPL7889,
SCHEMBL2483776,
HMS3653D13,
AOB87385,
BCP09582,
EX-A1120,
2440AH,
BDBM50015448,
MFCD28099806,
s7523,
ZINC98208742,
AKOS027295322,
GS9973 pound Entospletinib pound(c),
CS-2791,
DB12121,
SB16830,
NCGC00378596-07,
AC-30236,
AK270503,
AS-17026,
HY-15968,
FT-0700130,
SW220048-1,
J-690079,
6-(1H-indazol-6-yl)-N-(4-morpholin-4-ylphenyl)imidazo[1,2-a]pyrazin-8-amine,
6-Cyclopropyl-8-fluoro-2-[2-(hydroxymethyl)-3-(1-methyl-5-{[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino}-6-oxo-1,6-dihydro-3-pyridi nyl)phenyl]-1(2H)-isoquinolinone,
D0G9AW,
ACN-038133,
B3553,
A13884,
6-(1H-indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]- Imidazo[1,2-a]pyrazin-8-amine(GS-9973),